Common RNA Modification Linked to ALS Neurodegeneration
Scientists studied the m6A RNA modification finding that it is pivotal in TDP-43-related neurodegeneration in ALS.
Scientists studied the m6A RNA modification finding that it is pivotal in TDP-43-related neurodegeneration in ALS.
Study reveals pathway that could enhance the survival of cells and prevent further vascular damage in people with ALS.
Cedars-Sinai investigators confirm the safety of a novel stem cell and gene therapy targeting motor neurons that die in patients with ALS.
The immune system may play a fundamental role along with the central nervous system in ALS, Mount Sinai researchers report.
Read MoreIn JAMA Neurology, researchers outline preliminary research that could pave the way for a future test for earlier diagnosis of ALS.
Read MoreResearchers have identified a relationship between the patterns of ALS symptoms and microscopic changes in the brain and spinal cord.
Read MoreStealth BioTherapeutics Corp presents SBT-272 preclinical data demonstrating improvement in upper neuron function in ALS.
Read MoreThe Muscular Dystrophy Association will honor Major League Baseball’s recognition of Lou Gehrig Day at games across the country in June.
Read MoreTeam Gleason and Synchron announce a partnership agreement to provide patient-focused feedback on their platform to transform daily life.
Read MoreSilence ALS initiative will offer an integrated solution to identify, support and potentially treat nano-rare ALS patients.
Read MoreProMIS Neurosciences Inc announces new milestones in potential therapeutic approaches for ALS, the company notes in a media release.
Read MoreTarget ALS announces Merit E. Cudkowicz as the winner of the first annual Target ALS Rebecca Luker Courage Award.
Read MoreMDA announces programming and events in support of people living with ALS throughout ALS Awareness Month in May.
Read MoreWeizmann Institute of Science researchers link a new gene to ALS that plays a defensive, rather than an offensive, role in the disease.
Read MoreJohns Hopkins Medicine researchers have found a possible window of opportunity during ALS treatment to target astrocyte abnormalities.
Read MoreA brain-computer interface (aka brain implant) is safe and allows participants to use a computer to communicate by text and do daily tasks.
Read MoreProfessor Kano Osamu, MD, PhD, and his colleagues conducted a study to evaluate the effect of HAL-based training in ALS patients.
Read MoreResearchers from University of Arizona are investigating an oral drug candidate that may benefit patients with Lou Gehrig’s disease, or ALS.
Read More